Notice: Our teams will be out of the office on Friday, April 7 in observance of a spring holiday.
Interested in learning more about the MyRisk test and your ordering options? Fill out the form below to get started.
Fill in your information below and we’ll send you an email with more information
By sharing your healthcare provider’s information, we can provide them with more education and information about hereditary cancer testing.
MyRisk with RiskScore® is a powerful tool that evaluates 48 genes to help healthcare providers identify their patients’ risk of developing 11 different types of hereditary cancer.
More than a test, MyRisk’s clear, actionable results are the foundation for personalized care plans that can be used to help patients make confident, informed decisions about their medical management.
MyRisk with RiskScore® is a powerful tool that evaluates 48 genes to help healthcare providers identify their patients’ risk of developing 11 different types of hereditary cancer. More than a test, MyRisk’s clear, actionable results are the foundation for personalized care plans that can be used to help patients make confident, informed decisions about their medical management.
For patients with family history of certain cancers, hereditary cancer testing is the primary way to determine if they are at an increased risk of developing specific types of cancer.
MyRisk with RiskScore evaluates 48 genes associated with hereditary cancer risk to identify genetic changes associated with an increased cancer risk. When combined with family history and other clinical factors, MyRisk with RiskScore provides each patient with a cancer risk assessment individualized to them.
Nearly 1 in 4 patients1 meet criteria for hereditary cancer testing
The MyRisk Management Tool offers personalized guidance for patients and providers to work together to reduce risk of developing cancer or detect it at an earlier, more treatable stage.
Because of the precision science behind MyRisk, 56% of patients2 qualify for a medical management change that may help lower cancer risk, as opposed to only 10% with other hereditary cancer tests.
As the only hereditary cancer test designed for patients of all ancestries, the RiskScore component of MyRisk gives patients both a five-year and lifetime risk estimate of developing breast cancer. This is calculated using a combination of clinical risk factors, family history, and unique genetic, ancestry-informed breast cancer risk markers.
Every MyRisk test report provides a personalized assessment of a patient’s hereditary cancer risk, providing healthcare providers and patients with clear information to make informed decisions about managing cancer risk.
MyRisk assesses patient risk beyond just positive or negative, offering the following results:
The MyRisk Management Tool offers personalized guidance for patients with a higher risk of cancer. These plans may include guidelines for increased surveillance, risk- reducing medications, and/or risk-reducing surgery.
Eligible patients will be provided with a RiskScore which gives a personalized estimate of their five-year and remaining lifetime risk for developing breast cancer, guiding more confident decisions in managing their breast cancer risk.
Myriad offers several MyRisk ordering options to better serve your patients and your practice, including portals for online ordering and options for sending MyRisk test kits directly to your patients’ homes.
Myriad Complete supports patients and healthcare providers throughout the genetic testing experience through pre-test education, transparent pricing and financial support, clear results reporting, and post-test education.
Real expert support
First-class support from our team of board-certified genetic counselors gives you on-demand access to the information you need for every patient, every test, every time.
Workflow solutions allow for simple integration of Myriad’s tests into routine clinical care and help patients better understand and benefit from their results.
MyRisk offers clinically actionable results and personalized medical management guidance to inform confident patient care.
Myriad is committed to providing patients with access to accurate and affordable genetic results through extensive coverage with most insurance plans and financial assistance programs.
Myriad believes in providing the most accurate and highest quality tests for patients. From hereditary cancer to precision medicine, our tests are designed to give clinicians and patients the most accurate answer possible.